Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis.
Clawson LL, Cudkowicz M, Krivickas L, Brooks BR, Sanjak M, Allred P, Atassi N, Swartz A, Steinhorn G, Uchil A, Riley KM, Yu H, Schoenfeld DA, Maragakis NJ; neals consortium. Clawson LL, et al. Among authors: schoenfeld da. Amyotroph Lateral Scler Frontotemporal Degener. 2018 May;19(3-4):250-258. doi: 10.1080/21678421.2017.1404108. Epub 2017 Nov 30. Amyotroph Lateral Scler Frontotemporal Degener. 2018. PMID: 29191052 Clinical Trial.
Design of phase II ALS clinical trials.
Schoenfeld DA, Cudkowicz M. Schoenfeld DA, et al. Amyotroph Lateral Scler. 2008;9(1):16-23. doi: 10.1080/17482960701875896. Amyotroph Lateral Scler. 2008. PMID: 18273715
The natural history of ALS is changing: improved survival.
Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. Qureshi M, et al. Among authors: schoenfeld da. Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):324-31. doi: 10.3109/17482960903009054. Amyotroph Lateral Scler. 2009. PMID: 19922119
Trial of celecoxib in amyotrophic lateral sclerosis.
Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Rothstein JD, Drachman DB. Cudkowicz ME, et al. Among authors: schoenfeld da. Ann Neurol. 2006 Jul;60(1):22-31. doi: 10.1002/ana.20903. Ann Neurol. 2006. PMID: 16802291 Clinical Trial.
Functional outcome measures as clinical trial endpoints in ALS.
Traynor BJ, Zhang H, Shefner JM, Schoenfeld D, Cudkowicz ME; NEALS Consortium. Traynor BJ, et al. Neurology. 2004 Nov 23;63(10):1933-5. doi: 10.1212/01.wnl.0000144345.49510.4e. Neurology. 2004. PMID: 15557515 Clinical Trial.
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M; Northeast and Canadian Amyotrophic Lateral Sclerosis consortia. Aggarwal SP, et al. Lancet Neurol. 2010 May;9(5):481-8. doi: 10.1016/S1474-4422(10)70068-5. Epub 2010 Apr 1. Lancet Neurol. 2010. PMID: 20363190 Free PMC article. Clinical Trial.
Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis.
van Blitterswijk M, Gulati S, Smoot E, Jaffa M, Maher N, Hyman BT, Ivinson AJ, Scherzer CR, Schoenfeld DA, Cudkowicz ME, Brown RH Jr, Bosco DA. van Blitterswijk M, et al. Among authors: schoenfeld da. Amyotroph Lateral Scler. 2011 Nov;12(6):430-8. doi: 10.3109/17482968.2011.585163. Amyotroph Lateral Scler. 2011. PMID: 22023190 Free PMC article.
280 results